309 related articles for article (PubMed ID: 23533454)
1. Chitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccine.
Li X; Min M; Du N; Gu Y; Hode T; Naylor M; Chen D; Nordquist RE; Chen WR
Clin Dev Immunol; 2013; 2013():387023. PubMed ID: 23533454
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapeutic effects of chitin in comparison with chitosan against Leishmania major infection.
Hoseini MH; Moradi M; Alimohammadian MH; Shahgoli VK; Darabi H; Rostami A
Parasitol Int; 2016 Apr; 65(2):99-104. PubMed ID: 26518128
[TBL] [Abstract][Full Text] [Related]
3. Immunostimulatory effect of chitosan and quaternary chitosan: A review of potential vaccine adjuvants.
Li X; Xing R; Xu C; Liu S; Qin Y; Li K; Yu H; Li P
Carbohydr Polym; 2021 Jul; 264():118050. PubMed ID: 33910752
[TBL] [Abstract][Full Text] [Related]
4. Antitumor Immunity Induced by Genetic Immunization with Chitosan Nanoparticle Formulated Adjuvanted for HPV-16 E7 DNA Vaccine.
Tahamtan A; Barati M; Tabarraei A; Mohebbi SR; Shirian S; Gorji A; Ghaemi A
Iran J Immunol; 2018 Dec; 15(4):269-280. PubMed ID: 30593741
[TBL] [Abstract][Full Text] [Related]
5. Immune stimulating activity of two new chitosan containing adjuvant formulations.
Seferian PG; Martinez ML
Vaccine; 2000 Nov; 19(6):661-8. PubMed ID: 11090719
[TBL] [Abstract][Full Text] [Related]
6. Applications of Chitosan Derivatives as Adjuvant for Nanoparticles Based Vaccines.
Narayanan RR; Maanvizhi S
Infect Disord Drug Targets; 2023; 23(3):e220922209066. PubMed ID: 36154588
[TBL] [Abstract][Full Text] [Related]
7. Polysaccharides as vaccine adjuvants.
Sun B; Yu S; Zhao D; Guo S; Wang X; Zhao K
Vaccine; 2018 Aug; 36(35):5226-5234. PubMed ID: 30057282
[TBL] [Abstract][Full Text] [Related]
8. Comparison of adjuvant efficacy of chitosan and aluminum hydroxide for intraperitoneally administered inactivated influenza H5N1 vaccine.
Chang H; Li X; Teng Y; Liang Y; Peng B; Fang F; Chen Z
DNA Cell Biol; 2010 Sep; 29(9):563-8. PubMed ID: 20380570
[TBL] [Abstract][Full Text] [Related]
9. Use of adjuvants for immunotherapy.
Circelli L; Tornesello M; Buonaguro FM; Buonaguro L
Hum Vaccin Immunother; 2017 Aug; 13(8):1774-1777. PubMed ID: 28604160
[TBL] [Abstract][Full Text] [Related]
10. Recent Progress of Chitosan Nanoparticles for the Development of Superior Delivery of Vaccines.
Nakashima M; Suga N; Ikeda Y; Yoshikawa S; Matsuda S
Discov Med; 2024 Mar; 36(182):457-466. PubMed ID: 38531787
[TBL] [Abstract][Full Text] [Related]
11. Chitosan hydrogel vaccine generates protective CD8 T cell memory against mouse melanoma.
Highton AJ; Kojarunchitt T; Girardin A; Hook S; Kemp RA
Immunol Cell Biol; 2015 Aug; 93(7):634-40. PubMed ID: 25708538
[TBL] [Abstract][Full Text] [Related]
12. Advances and Potential Applications of Chitosan Nanoparticles as a Delivery Carrier for the Mucosal Immunity of Vaccine.
Li D; Fu D; Kang H; Rong G; Jin Z; Wang X; Zhao K
Curr Drug Deliv; 2017; 14(1):27-35. PubMed ID: 27494157
[TBL] [Abstract][Full Text] [Related]
13. pH Sensitive phosphorylated chitosan hydrogel as vaccine delivery system for intramuscular immunization.
Wei J; Xue W; Yu X; Qiu X; Liu Z
J Biomater Appl; 2017 May; 31(10):1358-1369. PubMed ID: 28387574
[TBL] [Abstract][Full Text] [Related]
14. Recent advances on chitosan as an adjuvant for vaccine delivery.
Dmour I; Islam N
Int J Biol Macromol; 2022 Mar; 200():498-519. PubMed ID: 34973993
[TBL] [Abstract][Full Text] [Related]
15. Immunological activity of chitin and its derivatives.
Nishimura K; Nishimura S; Nishi N; Saiki I; Tokura S; Azuma I
Vaccine; 1984 Mar; 2(1):93-9. PubMed ID: 6397928
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory properties of chitosan polymers.
Moran HBT; Turley JL; Andersson M; Lavelle EC
Biomaterials; 2018 Nov; 184():1-9. PubMed ID: 30195140
[TBL] [Abstract][Full Text] [Related]
17. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pylori.
Xing Y; Liu W; Li X; Guo L; Lv X; Xi T
Biochem Biophys Res Commun; 2015 Jul; 462(3):269-74. PubMed ID: 25957472
[TBL] [Abstract][Full Text] [Related]
19. Chitin regulation of immune responses: an old molecule with new roles.
Lee CG; Da Silva CA; Lee JY; Hartl D; Elias JA
Curr Opin Immunol; 2008 Dec; 20(6):684-9. PubMed ID: 18938241
[TBL] [Abstract][Full Text] [Related]
20. Cancer vaccine adjuvants--recent clinical progress and future perspectives.
Banday AH; Jeelani S; Hruby VJ
Immunopharmacol Immunotoxicol; 2015 Feb; 37(1):1-11. PubMed ID: 25318595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
